What's Happening?
Leading health systems are refining their 503B outsourcing strategies to enhance patient safety and supply resilience during drug shortages and recalls. The session, featuring experts from Prisma Health, University Hospitals, and STAQ Pharma, explores
proven practices for evaluating outsourcing partners and building a culture of quality. The discussion highlights the importance of rigorous supplier evaluations, quality-driven culture assessments, and data sharing to improve safety and savings. Premier's 503B Outsourcing Optimization model has helped participating health systems achieve measurable outcomes, including significant savings through tier optimization and standardization, faster onboarding during recalls, and stronger compliance performance.
Why It's Important?
The focus on 503B pharmacy best practices is crucial for maintaining patient safety and ensuring uninterrupted care during drug shortages. By optimizing outsourcing strategies, health systems can better manage supply chain disruptions and enhance their readiness for market instability. This approach not only safeguards patient care but also contributes to cost savings and improved compliance performance. As drug shortages continue to challenge the healthcare industry, these strategies offer a proactive solution to mitigate risks and maintain high standards of care.
Beyond the Headlines
The emphasis on quality-driven culture and supplier evaluations in 503B pharmacy practices highlights the ethical and compliance dimensions of healthcare management. By prioritizing patient safety and supply resilience, health systems are addressing broader concerns about the reliability and integrity of pharmaceutical supply chains. This focus on quality and performance may lead to long-term shifts in how health systems approach outsourcing and supply chain management, potentially setting new industry standards for patient care and safety.
